Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

Affiliations

¹ 1 Center of Research of Immunopathology and Rare Diseases, Department of Clinical and Biological Sciences, University of Turin and S. Giovanni Bosco Hospital, Turin, Italy.
² 2 Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC), Reina Sofia University Hospital, Cordoba, Spain.

Free article

Comment

M Radin et al. Lupus. 2017 Nov.

Free article

. 2017 Nov;26(13):1457-1458.

doi: 10.1177/0961203317711014. Epub 2017 May 22.

¹ 1 Center of Research of Immunopathology and Rare Diseases, Department of Clinical and Biological Sciences, University of Turin and S. Giovanni Bosco Hospital, Turin, Italy.
² 2 Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC), Reina Sofia University Hospital, Cordoba, Spain.

No abstract available

Comment on

Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C, Jego P, Veyssier-Belot C, Marie I, Mekinian A, Elmaleh-Sachs A, Leroux G, Saadoun D, Oziol E, Fraisse T, Hyvernat H, Thiercein-Legrand MF, Sarrot-Reynauld F, Ferreira-Maldent N, de Menthon M, Goujard C, Khau D, Nguen Y, Monnier S, Michon A, Castel B, Decaux O, Piette JC, Cacoub P. Comarmond C, et al. Lupus. 2017 Oct;26(12):1291-1296. doi: 10.1177/0961203317699285. Epub 2017 Mar 29. Lupus. 2017. PMID: 28355985